Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Financial Engineering at American Oriental

publication date: Jun 5, 2008

American Oriental Bioengineering has generated more than its fair share of financial engineering news during the first four days of this week. On Monday, the company announced it would buy back up to $75 million of its shares. On Tuesday, the company announced plans to offer $125 million in aggregate liquidation preference convertible preferred stock, and on Thursday, it rescinded the convertible preferred stock offer, citing market conditions. We look at the announcements and compare them to the solid results of the company's business.  More details...

Stock Symbol: (NYSE: AOB) (OTCBB: CAXG)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital